Core Laboratories N.V. (CLB)
NYSE: CLB · IEX Real-Time Price · USD
17.92
-0.21 (-1.16%)
May 24, 2024, 4:00 PM EDT - Market closed

Core Laboratories Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019 2018 - 1994
Net Income
36.6819.4519.73-97.64101.98
Upgrade
Depreciation & Amortization
15.7817.1618.5220.8722.61
Upgrade
Share-Based Compensation
13.977.7619.097.3920.88
Upgrade
Other Operating Activities
-41.64-19.41-20.76127.24-55.94
Upgrade
Operating Cash Flow
24.7924.9636.5857.8789.53
Upgrade
Operating Cash Flow Growth
-0.67%-31.78%-36.79%-35.36%-19.94%
Upgrade
Capital Expenditures
-10.03-8.36-13.18-10.64-21.56
Upgrade
Acquisitions
00.240.87-0.2317.77
Upgrade
Other Investing Activities
3.384.262.0818.72-1.88
Upgrade
Investing Cash Flow
-6.65-3.86-10.227.85-5.68
Upgrade
Dividends Paid
-1.87-1.85-1.83-12.45-97.57
Upgrade
Share Issuance / Repurchase
-2.2-3.951.74-2.79-3.31
Upgrade
Debt Issued / Paid
-10.25-17.21-71-47.5415
Upgrade
Other Financing Activities
-4.12-0.41-1.37-0.230.01
Upgrade
Financing Cash Flow
-18.45-23.38-22.46-63.01-85.87
Upgrade
Net Cash Flow
-0.31-2.283.92.71-2.02
Upgrade
Free Cash Flow
14.7616.623.447.2267.97
Upgrade
Free Cash Flow Growth
-11.07%-29.06%-50.45%-30.52%-24.30%
Upgrade
Free Cash Flow Margin
2.90%3.39%4.98%9.69%10.17%
Upgrade
Free Cash Flow Per Share
0.320.360.511.061.53
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).